News, Analysis & Insights on Nutrition, Supplements, and Health
Last updated on
A new stabilized NADH, a form of B vitamin niacin also known as coenzyme 1, is set to enter the US market under an exclusive patent licensing agreement between Natrol and Austria's Oekopharm.
Natrol has been stunned by a dramatic fall in sales and operating margin during the second quarter, mainly due to a rapid decline in consumer demand for its low carb diet product and a sports nutrition product.
Supplement maker Natrol said this week that it will invest further in better product development and quality assurance to meet growing consumer demand for higher standards.